Aug22136 43. Best Life Sciences Clinical Safety & Compliance Consultancy 2026 As one of the world’s largest exporters of pharmaceuticals, Ireland offers a strategic base for global life science operations. The sector accounts for approximately 45% of total good exports, with exports reaching €99.9 billion in 2024. The country’s expanding sector has created significant demand for clinical safety and compliance consultancy services, and one company has risen to meet this demand head on. Arriello is a leading clinical safety and compliance consultancy dedicated to guiding life sciences companies through product development complexities. We explored the company’s outstanding operations below. Since 2008, Arriello has supported companies in bringing innovative therapies to market safely, efficiently, and compliantly. Serving as a trusted life sciences partner to pharma, biotech, and medtech organisations around the world, the company delivers a rare combination of fully integrated regulatory affairs, pharmacovigilance (PV), clinical safety, and quality and compliance services. Ultimately, its mission is to ensure that innovative therapies reach patients safely and efficiently by delivering solutions that are pragmatic, reliable, and tailored to each patient’s unique needs. From its headquarters in Dublin, Arriello helps clients accelerate clinical-to-commercial timelines, reduce operational and compliance risk, and scale internationally without additional internal overhead. The company works across all therapeutic areas, from small molecules to biologics and advanced therapies. It acts as an extension of each client’s teams, turning global regulatory and safety complexity into a competitive advantage. This service frees the client to focus on scientific innovation, whilst Arriello manages the safety, resilience, and compliance of their products in every market. The company supports therapies from early clinical development through launch, commercialisation, global expansion, and post-marketing evolution. In particular, it is well known for its capabilities in complex modalities such as gene therapies, CAR-T cell treatments, and next-generation oncology products. Clients recognise the niche expertise and nuanced understanding required to manage unique safety profiles and evolving regulatory requirements in these cutting-edge fields, and similar expertise is not widely available elsewhere. The area of clinical safety and pharmacovigilance has become a cornerstone of Arriello’s offerings, driven by rapid demand growth and the company’s own specialist expertise. Its comprehensive clinical safety and PV lifecycle management includes adverse event processing, signal detection, risk management plans (RMPs and REMS), aggregate reports (DSURs and PSURs), and end-to-end clinical safety programme management. It also provides services for regulatory affairs, including global regulatory strategy, CTA/IND and MAA submissions, lifecycle management, and full local affiliate and market-specific regulatory support. Clients consistently cite Arriello’s “exceptional client delivery” approach. The company integrates seamlessly into their teams, provide proactive strategic insights, maintain transparent communication, and solve problems with a partnership mindset. This has earned the team a reputation as a highly trusted, dependable global partner. This is supported by a global network of incountry experts providing Local Person for Pharmacovigilance and Local Safety Officer, medical affairs, and health authority liaison services that ensure compliance and product continuity across international markets. Ireland’s position as a global hub for the life sciences sector facilitates these exceptional services, offering a highly developed life sciences ecosystem and strong industry networks. The country benefits from excellent physical and logistical connectivity with Europe and the U.S., enjoying a unique geographical position that bridges North America and Europe both practically and psychologically for global organisations. Furthermore, Arriello leverages Dublin’s robust infrastructure, transport links, and international footprint to lead the charge in life sciences consultancy across Ireland. Looking to the future, Arriello will be focused on the continued expansion of its clinical safety and pharmacovigilance capabilities, with a particular investment in advanced therapies expertise. The company will also strengthen its technology-enabled PV and regulatory solutions to enhance efficiency, automation, and data quality. Its Local Affiliate footprint will be expanded to meet growing demand for global launch support, and an increased focus will be placed upon operational resilience and compliance innovation in response to evolving global regulatory frameworks. For almost two decades, Arriello has dedicated itself to helping innovative life sciences companies expedite the product development and commercialisation journey and reduce time to market. The company has leveraged deep scientific and industry knowledge to guide clients through even the most challenging product development complexities, delivering tailored and pragmatic advice with a customer-centric approach. With an unrivalled breadth of expertise, supported by a remarkable track record of success, Arriello has truly earned its status as the Best Life Sciences Clinical Safety and Compliance Consultancy 2026. Contact: Alan White and Anna Lukyanova (Founders and Co-CEOs) Company: Arriello Web Address: www.arriello.com AIM-Jan26071
RkJQdWJsaXNoZXIy MTUyMDQwMA==